Artiva Biotherapeutics, Inc. Common Stock

ARTVNASDAQ • USD
3.95 USD
↘ 0.07 (1.62%)🟢LIVE (AS OF 01:47 PM EST)
🟢Market: OPEN

ARTV is currently priced at $3.95. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest ARTV is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 13, 2026.

Open?$3.98
High?$4.06
Low?$3.93
Prev. Close?$4.01
Volume?904.4K
Avg. Volume?1.1M
VWAP?$3.99
Rel. Volume?0.85x
Bid / Ask
Bid?$3.95 × 100
Ask?$3.96 × 800
Spread?$0.01
Midpoint?$3.96
Valuation & Ratios
Market Cap?198.2M
Shares Out?49.4M
Float?13.6M
Float %?27.9%
P/E Ratio?N/A
P/B Ratio?0.62
EPS?-$1.98
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Employees
134
Market Cap
198.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2024-07-19
Address
5505 MOREHOUSE DRIVE
SAN DIEGO, CA 92121
Phone: (858) 267-4467
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
88
Momentum?
65
Short Sent.?
52
Piotroski F-Score?0/9Weak
Altman Z-Score?3.75Safe
Confidence?43%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?21.66%Squeeze Risk
Short Interest?3.0M
Days to Cover?1.8
Free Float13.6M
Avg Daily Volume1.6M
Settlement Date2026-10-30
Financial Health
Current Ratio?19.88Strong
Quick Ratio?19.88Strong
Cash Ratio?3.73Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.62CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
6
-30.6%WEAK▾
ROA?
S&P
3
-28.6%WEAK▾
Cash Flow & Enterprise
FCF?$-86601000
Enterprise Value?$137.0M
Fundamentals ratios updated end of day